Showing 64,121 - 64,140 results of 99,862 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (nn decrease)) ))', query time: 1.67s Refine Results
  1. 64121

    Table1_Identification of telomere-related lncRNAs and immunological analysis in ovarian cancer.docx by Weina Xu (558990)

    Published 2024
    “…The mRNA levels of PTPRD-AS1, SPAG5-AS1, FAM27E3, and AC018647.3 were significantly over-expressed in OC cell lines (SKOV3, A2780, CAOV3) in comparison to normal IOSE-80 cells. …”
  2. 64122

    DataSheet1_Identification of telomere-related lncRNAs and immunological analysis in ovarian cancer.docx by Weina Xu (558990)

    Published 2024
    “…The mRNA levels of PTPRD-AS1, SPAG5-AS1, FAM27E3, and AC018647.3 were significantly over-expressed in OC cell lines (SKOV3, A2780, CAOV3) in comparison to normal IOSE-80 cells. …”
  3. 64123

    Data_Sheet_1_Impact of New-Onset Persistent Left Bundle Branch Block on Reverse Cardiac Remodeling and Clinical Outcomes After Transcatheter Aortic Valve Replacement.docx by Kyu Kim (3412583)

    Published 2022
    “…However, the new LBBB group showed no significant changes in these parameters. During a median follow-up of 18.1 months, the new LBBB group experienced a higher incidence of primary outcomes [hazard ratio (HR): 5.03; 95% confidence interval (CI): 2.60–9.73; p < 0.001] and all-cause death (HR: 2.80; 95% CI: 1.38–5.69; p = 0.003). …”
  4. 64124

    Biomarker Benchmark - GSE37199 by Anna Guyer (1390293)

    Published 2016
    “…Gene signatures in the poor prognosis LPD group 1 were associated with increased CD71+ early erythroid cells and decreased B-cell and T-cell immune response. A 9-gene signature, that was validated by RT-PCR studies, classified patients as group LPD 1 with a very low misclassification rate (1.2%).…”
  5. 64125

    Ripmeester et al rDNA.pzfx by Marjolein Caron (12003290)

    Published 2022
    “…<p>BMP7 is a morphogen capable of counteracting the OA chondrocyte hypertrophic phenotype via NKX3-2. …”
  6. 64126

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…However, NPS-1034 is practically insoluble in almost all organic solvents as well as aqueous media (pH 1, 4.5, and 7.5). We attempted to improve the physicochemical properties of NPS-1034 by forming multicomponent systems with a wide variety of sulfonic acids including methanesulfonic acid, 1,2-ethanedisulfonic acid, <i>p</i>-toluenesulfonic acid, and camphorsulfonic acid. …”
  7. 64127

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…However, NPS-1034 is practically insoluble in almost all organic solvents as well as aqueous media (pH 1, 4.5, and 7.5). We attempted to improve the physicochemical properties of NPS-1034 by forming multicomponent systems with a wide variety of sulfonic acids including methanesulfonic acid, 1,2-ethanedisulfonic acid, <i>p</i>-toluenesulfonic acid, and camphorsulfonic acid. …”
  8. 64128

    Galantamine protects against lipopolysaccharide-induced acute lung injury in rats by G. Li (2960067)

    Published 2019
    “…Moreover, GAL treatment significantly decreased the mortality rate (ANOVA). In conclusion, we demonstrated that GAL exerted a protective effect on LPS-induced ALI in rats.…”
  9. 64129

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…However, NPS-1034 is practically insoluble in almost all organic solvents as well as aqueous media (pH 1, 4.5, and 7.5). We attempted to improve the physicochemical properties of NPS-1034 by forming multicomponent systems with a wide variety of sulfonic acids including methanesulfonic acid, 1,2-ethanedisulfonic acid, <i>p</i>-toluenesulfonic acid, and camphorsulfonic acid. …”
  10. 64130

    Peripheral inflammation increases the number of recombined Purkinje neurons. by Kirsten Ridder (571651)

    Published 2014
    “…Vertical line at 0 h indicates media exchange. Scale bar, 100 µm (A and B), 50 µm (D and F), 10 µm (E), and 5 µm (G).…”
  11. 64131

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…However, NPS-1034 is practically insoluble in almost all organic solvents as well as aqueous media (pH 1, 4.5, and 7.5). We attempted to improve the physicochemical properties of NPS-1034 by forming multicomponent systems with a wide variety of sulfonic acids including methanesulfonic acid, 1,2-ethanedisulfonic acid, <i>p</i>-toluenesulfonic acid, and camphorsulfonic acid. …”
  12. 64132

    Effect of inorganic phosphate on cell signaling protein expression. by Ai Peng (346588)

    Published 2013
    “…On the other hand, the cells exposed to simulated hypophosphatemia (0.5 mM) showed significantly decreased level of eNOS, but significantly increased CDK2, Akt, p-Akt, p-Mek, p38, p-p38, p53, PP2A, Stat1, p-PLCg2, PKCβ2, and Bcl-xl/Bax ratio. …”
  13. 64133

    Supplementary Material for: Anatomical, functional, and prognostic results of vitrectomy in epiretinal membranes secondary to retinal vein occlusions by Chung Y.-R. (20312844)

    Published 2024
    “…The mean VA of 0.9 ± 0.7 logMAR preoperatively improved to 0.5 ± 0.5 logMAR after 24 months (p=0.01). Anatomically, the mean preoperative CMT was 501 ± 168 μm, decreasing to 348 ± 108 μm at month 24 (p=0.008). …”
  14. 64134

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…However, NPS-1034 is practically insoluble in almost all organic solvents as well as aqueous media (pH 1, 4.5, and 7.5). We attempted to improve the physicochemical properties of NPS-1034 by forming multicomponent systems with a wide variety of sulfonic acids including methanesulfonic acid, 1,2-ethanedisulfonic acid, <i>p</i>-toluenesulfonic acid, and camphorsulfonic acid. …”
  15. 64135

    Vaccine induced protection against leukopenia. by Simon P. Graham (59745)

    Published 2013
    “…<p>Leucokyte numbers remained at pre-vaccination levels throughout the experiment in animals vaccinated five days prior to challenge with A) UK2000/7.1 or B) CBR/93 (filled circles), whereas a significant (P<0.05) decrease occurred rapidly after challenge in unvaccinated animals (open circles) and animals vaccinated one day before challenge that developed clinical signs and were euthanized prior to the end of the experiment (open triangles). …”
  16. 64136

    Table_1_Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinoma.xlsx by Xia Liu (117318)

    Published 2023
    “…As older patients age, organ function decreases, leading to increased adverse reactions to treatment. …”
  17. 64137

    Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital by Fatemeh Nasri (8290011)

    Published 2025
    “…The criteria for heart failure in this study were defined as an ejection fraction (EF) of less than 50% or a decrease of greater than 10% in EF. Descriptive statistics, the chi-square statistical test, Fisher’s exact test, and logistic regression analyses were employed to assess the variables. …”
  18. 64138

    MAP, HR, and CBF Changes Induced by sGVS. by Devin W. McBride (492631)

    Published 2016
    “…<p><b>(A)</b> MAP tends to decrease during sGVS (p<0.1). …”
  19. 64139

    Effect of Pol I transcription blocks and transcription rate on SNORD44 and its sdRNA and long form. by Baoyan Bai (388372)

    Published 2014
    “…<p>(<i>A, B</i>) HeLa cells were treated with Actinomycin D (Act D, 50 ng/ml) and incubated for 3 hours. …”
  20. 64140

    Period of latency, progression and duration of blockade of epidural anesthesia with lidocaine, bupivacaine or its association in dogs by S.J. Ronchi (8143470)

    Published 2019
    “…Eighteen dogs were allocated in three groups, which received epidural: lidocaine 2% (GL) 0.25ml / kg; bupivacaine 0.5% (GB) in the same volume, or the association of both (GLB) in a 1: 1 ratio. …”